Evidence map›Paper›PMID 30867888›Full record

ArticleOxidative medicine and cellular longevity2019

Increased Transfection of the Easily Oxidizable GC-Rich DNA Fragments into the MCF7 Breast Cancer Cell.

Svetlana V Kostyuk, Nadezhda N Mordkovich, Natalya A Okorokova, Vladimir P Veiko, Elena M Malinovskaya, Elizaveta S Ershova, Marina S Konkova, Ekaterina A Savinova, Maria A Borzikova, Tatiana A Muzaffarova and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Svetlana V KostyukResearch Centre for Medical Genetics (RCMG), Moscow 115478, Russia.ORCID 0000-0003-2116-1244
Nadezhda N MordkovichBach Institute of Biochemistry, Biotechnology Research Center, Russian Academy of Sciences, Moscow 119071, Russia.
Natalya A OkorokovaBach Institute of Biochemistry, Biotechnology Research Center, Russian Academy of Sciences, Moscow 119071, Russia.
Vladimir P VeikoBach Institute of Biochemistry, Biotechnology Research Center, Russian Academy of Sciences, Moscow 119071, Russia.
Elena M MalinovskayaResearch Centre for Medical Genetics (RCMG), Moscow 115478, Russia.
Elizaveta S ErshovaResearch Centre for Medical Genetics (RCMG), Moscow 115478, Russia.
Marina S KonkovaResearch Centre for Medical Genetics (RCMG), Moscow 115478, Russia.ORCID 0000-0003-4734-7178
Ekaterina A SavinovaResearch Centre for Medical Genetics (RCMG), Moscow 115478, Russia.
Maria A BorzikovaResearch Centre for Medical Genetics (RCMG), Moscow 115478, Russia.
Tatiana A MuzaffarovaResearch Centre for Medical Genetics (RCMG), Moscow 115478, Russia.
Lev N PorokhovnikResearch Centre for Medical Genetics (RCMG), Moscow 115478, Russia.ORCID 0000-0002-3664-6685
Nataly N VeikoResearch Centre for Medical Genetics (RCMG), Moscow 115478, Russia.
Serguey I KutsevResearch Centre for Medical Genetics (RCMG), Moscow 115478, Russia.
Research Centre for Medical Genetics · RUA N Bach Institute of Biochemistry · RUPirogov Russian National Research Medical University · RUSechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveEasily oxidizable GC-rich DNA (GC-DNA) fragments accumulate in the cell-free DNA (cfDNA) of patients with various diseases. The human oxidized DNA penetrates the MCF7 breast cancer cells and significantly changes their physiology. It can be assumed that readily oxidizable GC-DNA fragments can penetrate the cancer cells and be expressed.

methodsMCF7 cells were cultured in the presence of two types of GC-DNA probes: (1) vectors pBR322 and pEGFP and (2) plasmids carrying inserted human rDNA (pBR322-rDNA and pEGFP-rDNA). pEGFP and pEGFP-rDNA contained a CMV promoter and a fluorescent protein gene

resultsWhen GC-DNA is added to the cell culture medium, it interacts with the cell surface. At the site of GC-DNA contact with the cell, NOX4 is expressed, and ROS level increases. The ROS oxidize the GC-DNA. When using the plasmids pEGFP and pEGFP-rDNA, an increase in the amount of the DNA

conclusionsGC-rich cfDNA fragments that are prone to oxidation can easily penetrate the cancer cells and be expressed. The cfDNA should become a target for the antitumor therapy.

Indexed as

Breast NeoplasmsDNAGenetic VectorsHumansMCF-7 CellsTransfectionDNA

Identifiers

PMID30867888
PMCPMC6379852
OpenAlexW2912456417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.